Skip to main content
. Author manuscript; available in PMC: 2014 Jul 22.
Published in final edited form as: Cancer Biol Ther. 2008 Sep 4;7(9):1418–1426. doi: 10.4161/cbt.7.9.6430

Figure 4.

Figure 4

(A) Plotting of competitive binding of ApoG2 and (-)-gossypol to purified recombinant Bcl-2 protein. (B) Treatment of WSU-DLCL2 with ApoG2 interferes with the formation of heterodimers between Bcl-XL and Bim. Co-immunoprecipitation with anti-Bcl-XL antibody; Western blot with anti-Bim and anti-Bcl-XL antibodies. (C) Western blot of whole cell lysate with anti-Bim and anti-Bcl-XL antibodies. β-actin was probed to show loading of equal amount of protein lysate.